Patents Assigned to Intarcia Therapeutics, Inc.
  • Oxidized collagen formulations for use with non-compatible pharmaceutical agents
    Patent number: 7011851
    Abstract: Disclosed are oxidized collagen compositions wherein the thiomethyl group of one or more of the methionine residues of the collagen have been replaced with methylsulfoxy and/or methylsulfonyl groups.
    Type: Grant
    Filed: September 4, 2003
    Date of Patent: March 14, 2006
    Assignee: Intarcia Therapeutics, Inc.
    Inventors: David J. Burke, Son I. Kuan